Mechanistically, circVAMP3 directly binds to LDHA, elevates its Y10 phosphorylation through the upstream kinase FGFR1, and then enhances the enzymatic activity of LDHA, contributing to elevated glycolytic levels and promoting proliferation in RCC cells, as shown in Fig. 8. Here, LDHA is linked to renal cell carcinoma.